Dow Chemical and Olin Corporation completed their chlor-alkali, chlorinated organics and epoxy asset merger at the beginning of the third quarter and have appointed new executives to the combined company that will operate under the Olin umbrella.

The two new directors, designated by Dow in connection with the Reverse Morris Trust transaction, are William H. Weideman and Carol A. Williams.

During his 38 years at Dow, Weideman, 61, served in senior financial and management roles across Dow's portfolio of businesses and in his last position was chief financial officer and executive vice president from March 2010 to January 2015. He is also on the board of directors of Sadara Chemical Company, the joint venture with SABIC.

Williams, 57, served as a special advisor to the Dow CEO Andrew Liveris until early 2015. Prior to this, she was the chemical giant’s executive vice president of manufacturing and engineering, supply chain and environmental, health & safety operations. In an earlier position she was vice president for the North American chlor-alkali business.